ENTITY

Grifols (GRF SQ)

-1
Analysis
Health CareSpain
Grifols S.A. develops, manufactures, and markets plasma derivatives, IV Therapy, enteral nutrition, diagnostic systems, and medical materials.
more
bullishGrifols SA
16 Feb 2023 18:58

Liquid Universe of European Ordinary and Preferred Shares: February ‘23 Report

Since mid-January, spreads have generally tightened across our liquid universe (8 have widened, 10 tightened, 1 at same level).

Share
bearishGrifols SA
16 Nov 2022 23:03

Liquid Universe of European Ordinary and Preferred Shares: November ‘22 Report

Since mid-September, spreads have shown a mixed performance across our liquid universe with a slight bias towards widening (10 have widened, 8...

Share
bullishGrifols SA
17 Oct 2022 12:52

Liquid Universe of European Ordinary and Preferred Shares: October ‘22 Report

Since mid-September, spreads have shown a mixed performance across our liquid universe with a slight bias towards widening.

Share
bearishGrifols SA
17 Sep 2022 00:02

Liquid Universe of European Ordinary and Preferred Shares: September ‘22 Report

Since mid-August, spreads have shown a mixed performance across our liquid universe with a slight bias towards tightening (with the exception of...

Share
bearishBiotest AG
28 Jan 2022 17:05

Grifols/Biotest: Put Period

At the end of the additional offer acceptance period, Grifols has 96.2% of the voting rights and holds 69.72% of the share capital of Biotest. The...

Share
x